- Home
- CHRW vs ITCI Comparison
CHRW vs ITCI Comparison
Compare CHRW & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRW
- ITCI
- Stock Information
- Founded
- CHRW 1905
- ITCI 2002
- Country
- CHRW United States
- ITCI United States
- Employees
- CHRW N/A
- ITCI N/A
- Industry
- CHRW Oil Refining/Marketing
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- CHRW Consumer Discretionary
- ITCI Health Care
- Exchange
- CHRW Nasdaq
- ITCI Nasdaq
- Market Cap
- CHRW 12.3B
- ITCI 13.5B
- IPO Year
- CHRW 1997
- ITCI N/A
- Fundamental
- Price
- CHRW $96.39
- ITCI $131.23
- Analyst Decision
- CHRW Buy
- ITCI Buy
- Analyst Count
- CHRW 18
- ITCI 13
- Target Price
- CHRW $120.69
- ITCI $106.58
- AVG Volume (30 Days)
- CHRW 1.3M
- ITCI 2.3M
- Earning Date
- CHRW 04-30-2025
- ITCI 05-06-2025
- Dividend Yield
- CHRW 2.57%
- ITCI N/A
- EPS Growth
- CHRW 41.91
- ITCI N/A
- EPS
- CHRW 3.86
- ITCI N/A
- Revenue
- CHRW $17,724,956,000.00
- ITCI $680,852,000.00
- Revenue This Year
- CHRW $2.25
- ITCI $40.64
- Revenue Next Year
- CHRW $4.65
- ITCI $58.53
- P/E Ratio
- CHRW $24.92
- ITCI N/A
- Revenue Growth
- CHRW 0.73
- ITCI 46.62
- 52 Week Low
- CHRW $65.00
- ITCI $63.30
- 52 Week High
- CHRW $114.82
- ITCI $131.37
- Technical
- Relative Strength Index (RSI)
- CHRW 42.97
- ITCI 85.05
- Support Level
- CHRW $95.08
- ITCI $131.20
- Resistance Level
- CHRW $105.27
- ITCI $131.37
- Average True Range (ATR)
- CHRW 2.77
- ITCI 0.27
- MACD
- CHRW -0.10
- ITCI -0.56
- Stochastic Oscillator
- CHRW 19.53
- ITCI 96.40
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.